Santa Cruz Biotechnology offers a broad range of MRP-S23 monoclonal antibodies for research focused on understanding MRP-S23 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MRP-S23, a component of the mitochondrial ribosome, plays a crucial role in protein synthesis within mitochondria, which is essential for cellular energy production and metabolism. Its proper function is vital for maintaining mitochondrial integrity and overall cellular health. Dysregulation of MRP-S23 has been implicated in various diseases, highlighting its importance as a target for therapeutic intervention. Research has shown that MRP-S23 is particularly active in tissues with high energy demands, such as heart and skeletal muscle. Understanding MRP-S23 expression patterns and interactions can provide valuable insights into mitochondrial diseases and potential treatment strategies. Recent studies have revealed new aspects of MRP-S23's involvement in cellular stress responses and adaptation mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of MRP-S23's role in cellular function and disease mechanisms.